Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer

Plain-language summary

This study assesses how frequently Lynch syndrome (an inherited cancer predisposition) occurs among patients with colorectal cancer. It enrolls patients aged 18 and older with histologically confirmed colon adenocarcinoma who have not previously been treated for this tumor. It is a multicenter registry study without a phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

State Scientific Centre of Coloproctology, Russian Federation

Start date

8/1/2022

Estimated completion

12/31/2028

Countries

Russia

Related genes

Locations

• Moscow, Russia

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Provision of written informed consent;
* Patients with histologically verified colon adenocarcinoma or patients with histologically verified synchronous neoplasms who have not previously received treatment for a second tumor;
* Age ≥ 18 years;
* Absence of antitumor treatment for a real tumor (it is allowed to include patients who have a history of antitumor treatment for other malignant tumors, if the period after treatment is more than 12 months).
* The ability of the patient, according to the Researcher, to fulfill the requirements of the Protocol;

Exclusion Criteria:

\- Patients receiving chemotherapy or radiotherapy for colon cancer at the time of screening